SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+11.27%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$629M
AUM Growth
+$55.9M
(+9.7%)
Cap. Flow
-$334K
Cap. Flow
% of AUM
-0.05%
Top 10 Holdings %
Top 10 Hldgs %
38.9%
Holding
144
New
36
Increased
32
Reduced
27
Closed
33
Top Buys
| 1 |
Gilead Sciences
GILD
|
$25.1M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$19.2M |
| 3 |
Amgen
AMGN
|
$18.5M |
| 4 |
BLUE
bluebird bio
BLUE
|
$11.4M |
| 5 |
GSK
GSK
|
$10.7M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$28.5M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$14.3M |
| 3 |
Sarepta Therapeutics
SRPT
|
$13.7M |
| 4 |
SHPG
Shire pic
SHPG
|
$11.8M |
| 5 |
Amicus Therapeutics
FOLD
|
$10.3M |
Sector Composition
| 1 | Healthcare | 83.93% |
| 2 | Technology | 7.06% |
| 3 | Industrials | 1.82% |
| 4 | Consumer Discretionary | 1.62% |
| 5 | Financials | 1.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBBP
51
DELISTED
Strongbridge Biopharma plc.
SBBP
| $4.04M | 0.56% |
+673,996
| New | +$4.04M |
|
52
Xenon Pharmaceuticals
XENE
$2.99B
| $4.04M | 0.56% |
+439,034
| New | +$4.04M |
|
53
Kezar Life Sciences
KZR
$28.5M
| $3.94M | 0.54% |
+22,790
| New | +$3.94M |
|
|
CBIO
54
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| $3.87M | 0.53% |
2,399
+899
| +60% | +$1.45M |
|
55
Meta Platforms (Facebook)
META
$1.85T
| $3.71M | 0.51% |
19,100
+13,003
| +213% | +$2.53M |
|
56
Alphabet (Google) Class A
GOOGL
$2.79T
| $3.69M | 0.51% |
65,380
-30,460
| -32% | -$1.72M |
|
57
Corvus Pharmaceuticals
CRVS
$419M
| $3.69M | 0.51% |
335,987
+14,557
| +5% | +$160K |
|
|
OBSV
58
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $3.69M | 0.51% |
243,669
-501,528
| -67% | -$7.59M |
|
59
Flex
FLEX
$20.1B
| $3.67M | 0.51% |
344,786
-63,716
| -16% | -$677K |
|
|
DCPH
60
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $3.66M | 0.5% |
93,031
+52,185
| +128% | +$2.05M |
|
61
ProQR Therapeutics
PRQR
$256M
| $3.6M | 0.5% |
493,749
-164,751
| -25% | -$1.2M |
|
62
Abeona Therapeutics
ABEO
$356M
| $3.57M | 0.49% |
8,927
-2,873
| -24% | -$1.15M |
|
63
Evoke Pharma
EVOK
$8.26M
| $3.53M | 0.49% |
9,798
+7,063
| +258% | +$2.54M |
|
64
Caesarstone
CSTE
$49.1M
| $3.49M | 0.48% |
230,816
+218,621
| +1,793% | +$3.3M |
|
|
ALNA
65
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $3.48M | 0.48% |
267,349
-142,850
| -35% | -$1.86M |
|
66
Vertex Pharmaceuticals
VRTX
$102B
| $3.4M | 0.47% |
+20,000
| New | +$3.4M |
|
|
SRRA
67
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $3.18M | 0.44% |
26,895
+1,895
| +8% | +$224K |
|
68
O'Reilly Automotive
ORLY
$88.1B
| $2.97M | 0.41% |
162,660
| – | – |
|
69
WIX.com
WIX
$8.05B
| $2.96M | 0.41% |
+29,542
| New | +$2.96M |
|
70
Q32 Bio
QTTB
$20.9M
| $2.89M | 0.4% |
7,880
+491
| +7% | +$180K |
|
|
ELOX
71
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $2.86M | 0.39% |
+4,187
| New | +$2.86M |
|
|
FSCT
72
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $2.62M | 0.36% |
+76,400
| New | +$2.62M |
|
73
Lam Research
LRCX
$124B
| $2.52M | 0.35% |
145,970
+12,410
| +9% | +$214K |
|
74
Verrica Pharmaceuticals
VRCA
$49.4M
| $2.48M | 0.34% |
+12,580
| New | +$2.48M |
|
|
APTX
75
DELISTED
Aptinyx Inc. Common Stock
APTX
| $2.48M | 0.34% |
+102,474
| New | +$2.48M |
|